Ryan Zimmerman
Stock Analyst at BTIG
(3.96)
# 621
Out of 5,006 analysts
191
Total ratings
50.93%
Success rate
10.75%
Average return
Main Sectors:
Stocks Rated by Ryan Zimmerman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Reiterates: Buy | $571 | $449.69 | +26.98% | 19 | Oct 1, 2025 | |
| ORGO Organogenesis Holdings | Reiterates: Buy | $7 | $4.20 | +66.67% | 7 | Sep 26, 2025 | |
| VCEL Vericel | Downgrades: Neutral | n/a | $33.74 | - | 9 | Sep 17, 2025 | |
| PRCT PROCEPT BioRobotics | Reiterates: Neutral | n/a | $35.24 | - | 2 | Sep 16, 2025 | |
| GKOS Glaukos | Reiterates: Buy | $118 | $86.62 | +36.23% | 11 | Sep 10, 2025 | |
| SI Shoulder Innovations | Reiterates: Buy | $23 | $13.08 | +75.84% | 1 | Sep 9, 2025 | |
| KIDS OrthoPediatrics | Maintains: Buy | $40 → $39 | $18.24 | +113.82% | 8 | Aug 6, 2025 | |
| ABT Abbott Laboratories | Maintains: Buy | $145 → $148 | $133.74 | +10.66% | 7 | Jul 14, 2025 | |
| RXST RxSight | Downgrades: Neutral | n/a | $8.49 | - | 5 | Jul 9, 2025 | |
| GMED Globus Medical | Downgrades: Neutral | n/a | $60.17 | - | 15 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $232 → $270 | $255.61 | +5.63% | 19 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $383 → $394 | $366.28 | +7.57% | 15 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.48 | +303.23% | 4 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $104 → $106 | $76.78 | +38.06% | 11 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $14.50 | - | 6 | Oct 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $134 → $126 | $98.83 | +27.49% | 7 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $100 | $76.41 | +30.87% | 2 | Sep 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $73.78 | - | 1 | Sep 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $46 → $53 | $26.83 | +97.54% | 7 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $3 | $0.69 | +334.78% | 2 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.30 | - | 5 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.52 | - | 3 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $4 | $2.42 | +65.29% | 1 | Jan 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.91 | - | 3 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.17 | - | 2 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 → $28 | $15.17 | +84.57% | 4 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $200 | $148.13 | +35.02% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $340 → $350 | $311.69 | +12.29% | 1 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $138 → $128 | $98.43 | +30.04% | 4 | Dec 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $12.08 | +24.17% | 1 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $84 → $91 | $67.34 | +35.14% | 1 | Feb 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $17.71 | +137.15% | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $53 | $5.01 | +947.90% | 3 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $17.16 | - | 3 | Apr 2, 2020 |
Intuitive Surgical
Oct 1, 2025
Reiterates: Buy
Price Target: $571
Current: $449.69
Upside: +26.98%
Organogenesis Holdings
Sep 26, 2025
Reiterates: Buy
Price Target: $7
Current: $4.20
Upside: +66.67%
Vericel
Sep 17, 2025
Downgrades: Neutral
Price Target: n/a
Current: $33.74
Upside: -
PROCEPT BioRobotics
Sep 16, 2025
Reiterates: Neutral
Price Target: n/a
Current: $35.24
Upside: -
Glaukos
Sep 10, 2025
Reiterates: Buy
Price Target: $118
Current: $86.62
Upside: +36.23%
Shoulder Innovations
Sep 9, 2025
Reiterates: Buy
Price Target: $23
Current: $13.08
Upside: +75.84%
OrthoPediatrics
Aug 6, 2025
Maintains: Buy
Price Target: $40 → $39
Current: $18.24
Upside: +113.82%
Abbott Laboratories
Jul 14, 2025
Maintains: Buy
Price Target: $145 → $148
Current: $133.74
Upside: +10.66%
RxSight
Jul 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.49
Upside: -
Globus Medical
May 27, 2025
Downgrades: Neutral
Price Target: n/a
Current: $60.17
Upside: -
Nov 26, 2024
Maintains: Buy
Price Target: $232 → $270
Current: $255.61
Upside: +5.63%
Oct 30, 2024
Maintains: Buy
Price Target: $383 → $394
Current: $366.28
Upside: +7.57%
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $2.48
Upside: +303.23%
Oct 14, 2024
Maintains: Buy
Price Target: $104 → $106
Current: $76.78
Upside: +38.06%
Oct 7, 2024
Upgrades: Neutral
Price Target: n/a
Current: $14.50
Upside: -
Oct 3, 2024
Maintains: Buy
Price Target: $134 → $126
Current: $98.83
Upside: +27.49%
Sep 18, 2024
Upgrades: Buy
Price Target: $100
Current: $76.41
Upside: +30.87%
Sep 5, 2024
Initiates: Neutral
Price Target: n/a
Current: $73.78
Upside: -
Jul 15, 2024
Maintains: Buy
Price Target: $46 → $53
Current: $26.83
Upside: +97.54%
May 16, 2024
Maintains: Buy
Price Target: $2 → $3
Current: $0.69
Upside: +334.78%
May 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $6.30
Upside: -
Apr 11, 2024
Downgrades: Neutral
Price Target: n/a
Current: $5.52
Upside: -
Jan 23, 2024
Initiates: Buy
Price Target: $4
Current: $2.42
Upside: +65.29%
Nov 14, 2023
Downgrades: Neutral
Price Target: n/a
Current: $6.91
Upside: -
Sep 12, 2023
Downgrades: Neutral
Price Target: n/a
Current: $14.17
Upside: -
Apr 17, 2023
Maintains: Buy
Price Target: $27 → $28
Current: $15.17
Upside: +84.57%
Apr 17, 2023
Maintains: Buy
Price Target: $195 → $200
Current: $148.13
Upside: +35.02%
Apr 17, 2023
Maintains: Buy
Price Target: $340 → $350
Current: $311.69
Upside: +12.29%
Dec 17, 2021
Maintains: Buy
Price Target: $138 → $128
Current: $98.43
Upside: +30.04%
Nov 22, 2021
Initiates: Buy
Price Target: $15
Current: $12.08
Upside: +24.17%
Feb 22, 2021
Maintains: Buy
Price Target: $84 → $91
Current: $67.34
Upside: +35.14%
Sep 23, 2020
Initiates: Buy
Price Target: $42
Current: $17.71
Upside: +137.15%
Aug 14, 2020
Upgrades: Buy
Price Target: $53
Current: $5.01
Upside: +947.90%
Apr 2, 2020
Downgrades: Neutral
Price Target: n/a
Current: $17.16
Upside: -